Diffusion-weighted MR imaging in a case of mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike

K Yonemura1, Y Hasegawa, K Kimura

  • 1Department of Medicine, National Cardiovascular Center, Suita, Osaka, Japan.

Insights

Diffusion-weighted MRI can help distinguish strokelike episodes in mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes (MELAS) from acute ischemic stroke. This finding aids in understanding MELAS-related brain changes.

Area of Science:

  • Neurology
  • Radiology
  • Mitochondrial Diseases

Background:

  • Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes (MELAS) is a rare genetic disorder.
  • Strokelike episodes in MELAS can mimic acute ischemic stroke on neuroimaging.
  • Accurate differentiation is crucial for appropriate patient management.

Observation:

  • T2- and diffusion-weighted MRI in a MELAS patient showed occipital lobe hyperintensities post-strokelike episodes.
  • No significant reduction in apparent diffusion coefficient (ADC) was observed in these lesions.
  • Single-photon emission CT (SPECT) suggested vasogenic edema and hyperperfusion.

Findings:

  • Apparent diffusion coefficient (ADC) mapping may differentiate MELAS strokelike episodes from acute ischemic stroke.
  • The observed MRI findings suggest vasogenic edema and hyperperfusion in MELAS strokelike episodes.
  • Early post-episode imaging is key for identifying characteristic MELAS changes.

Implications:

  • ADC mapping offers a potential tool for non-invasive diagnosis of MELAS-related events.
  • Understanding the pathophysiology of MELAS strokelike episodes can guide future therapeutic strategies.
  • Improved diagnostic accuracy can lead to better patient outcomes and prognostication.

Related Concept Videos